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SUMMARY - The aim of the study was to assess the possible correlation between catecholamine 
and cortisol levels and changes in cerebral hemodynamics in patients with chronic posttraumatic 
stress disorder (PTSD). The study included 50 patients with chronic PTSD first ever hospitalized 
for psychiatric treatment and 50 healthy control subjects. A11 study subjects were aged 30-50. In 
PTSD patients, 24-h urine levels of the epinephrine and norepinephrine metabolites vanillylman-
delic acid (VMA) and cortisol were determined and transcranial Doppler ultrasonography was per-
formed on day 1 of hospital stay and repeated after 21-day psychiatric medicamentous treatment. 
On initial testing, increased level of24-h VMA, decreased cortisol level and elevated mean blood 
flow velocity (MBFV) in the circle of Willis vessels were recorded in 25 (50.00%) patients. Repeat 
findings obtained after 21-day psychopharmaceutical therapy showed increased 24-h VMA, decre-
ased cortisol and elevated MBFV in the circle of Willis vessels in seven (14.00%) patients (initial vs. 
repeat testing, P=0.0002). Such parameters were not recorded in any of the control subjects (initial 
PTSD patient testing vs. control group, P=O.OOOO). Study results pointed to a significant correlation 
between increased catecholamine levels, decreased cortisol level and elevated MBFV in the circle 
of Willis vessels caused by cerebral vasospasm. Psychiatric medicamentous therapy administered 
for three weeks significantly reduced the proportion of patients with concurrently altered cerebral 
hemodynamics, increased levels of catecholamine metabolites and decreased level of cortisol. 
Key words: Stress disorders, post-traumatic; Stress disorders, post-traumatic - physiopathology; Cerebro-
vascular circulation -physiology; Cerebral hemorrhage - etiology; Cerebral hemorrhage - physiopathology; 
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Introduction 
Although mental disturbances in war veterans 
were observed as early as the 19th century, indepth re-
search into the posttraumatic stress disorder (PTSD) 
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was only initiated after World War 1]1-3 Considering 
the growing rate of traumatic events in today's world 
(natural disasters, traffic accidents, marine and air 
disasters, wars, terrorist attacks, murders, rape, etc.) 
that are associated with potent traumatic stressors, 
PTSD has become one of the major public health 
problems4,5. Physical manifestations of stress accom-
panied by mental disturbances and clinical picture 
of chronic PTSD are well known. In patients with 
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chronic PTSD, increased sympathetic activity is man-
ifested by elevated blood pressure, enhanced pulse rate 
and hyperventilation6,? Elevated level of vanillylman-
delic acid (VMA) as a catecholamine end metabolite 
and reduced level of cortisol have been demonstrated 
in chronic PTSD patientss.9 Transcranial Doppler 
(TCD) changes in terms of elevated mean blood flow 
velocity (MBFV) in the circle of Willis vessels have 
also been reported. The frequency spectrum charac-
teristics and parameters of frequency spectrum analy-
sis pointed to cerebral vasospasm10,11. In addition, 
other risk factors for cerebrovascular disease, e.g., 
cigarette smoking, alcoholism, arterial hypertension, 
hyperlipidemia and diabetes mellitus, are known to 
be more frequently present in chronic PTSD patients, 
favoring the development of atherosclerotic process 
and cardiovascular impairments12-16 . These new con-
cepts pose the need of target studies and long-term 
monitoring of patients with chronic PTSD. The aim 
of the present study was to identify the possible cor-
relation between catecholamine and cortisol levels 
and the above mentioned changes of cerebral hemo-
dynamics in chronic PTSD patients, and to monitor 
the effects of psychiatric medicamentous treatment on 
these parameters. 
Patients and Methods 
The study included 50 Croatian war veterans 
aged 30-50 years. Before the war, they were free 
from any mental or somatic diseases. The diagnosis 
of PTSD according to DSM-IV and ICD-10 diag-
nostic criteria17,18 was made by a psychiatrist on the 
basis of a psychological test. The findings of heart and 
lung x-ray, electrocardiography and extracranial color 
Doppler of carotid and vertebral arteries were normal 
in all study patients. The patients were hospitalized at 
Department of Psychiatry, Dr. Josip BenceviC Gen-
eral Hospital in Slavonski Brod, Croatia. Control 
group consisted of 50 age-matched subjects that had 
not been engaged in war actions and did not suffer 
from PTSD or any other psychiatric disorder. During 
the war, these subjects were living in areas free from 
war actions. 
On day 1 of admission, VMA and cortisol levels 
in 24-h urine were determined and TCD of cerebral 
circulation was performed in study patients. Patients 
having taken banana, vanilla, chocolate, coffee or al-
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cohol in the preceding three days and those on corti-
costeroid therapy were excluded for the possible in-
fluence on 24-h VMA and cortisol levels. Laboratory 
testing for adrenomedullary hormones was done by 
measuring the catecholamine end metabolite VMA 
in 24-h urine. Cortisol as a stress hormone was also 
determined in 24-h urine. Diurnal oscillations in the 
catecholamine and cortisol secretion and the impact 
of daily stressful situations that may increase their 
production were obviated by circadian measurement 
of the study parameters. Normal VMA level in 24-h 
urine is 10-35 ~molldU; levels greater than 35 ~moll 
dU are considered as being elevated. Normal cortisol 
level in 24-h urine is 55-276 nmolldU; levels lower 
than 55 nmolldU are considered as being decreased. 
TCD examination included measurement of MBFV 
in the circle of Willis vessels. Cerebral hemodynam-
ics was assessed by use of an EME Trans-scan 3D 
device with a 2 MHz probe. Standardized MBFV 
values expressed in centimeters per second (cm/s) were 
used. Elevated MBFV with typical frequency spec-
trum extensions were considered as reflecting cerebral 
vasospasm as a consequence of prolonged contraction 
of the cerebral artery smooth muscle walls19-21 . 
The examinations were repeated after 3-week hos-
pital stay and psychiatric treatment with antidepres-
sants and anxiolytics. These findings were compared 
with those from initial testing and with findings re-
corded in the control group of healthy subjects. 
On statistical analysis, the test of proportion be-
tween two groups was employed, with the level of sig-
nificance set at P<0.05. Based on the results obtained, 
correlation of particular subject groups with elevated 
catecholamine levels and changes in cerebral hemody-
namics was determined. 
Results 
Initial measurements showed concurrent 24-h 
VMA increase, 24-h cortisol decrease and presence 
of cerebral vasospasm in 25 of 50 (50.00%) patients 
with chronic PTSD. Upon 3-week psychopharma-
cotherapy, the same pattern of study parameters was 
recorded in seven (14.00%) patients. The difference 
was statistically significant (P=0.0002) (Table 1). 
None of the control group subjects had concurrently 
elevated 24-h VMA, decreased 24-h cortisol and ce-
rebral vasospasm. Difference between chronic PTSD 
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Table 1. Concurrent determination of elevated VMAJ decreased cortisol and cerebral 
vasospasm in PTSD patients: initial testing vs. repeat testing 
Group 
Eleva ted VMA + 
Other Total 
decreased cortisol + vasosEasm 
PTSD patients 
Initial testing 25 (50.00%) 25 (50.00%) 50 (100.00%) 
PTSD patients 
ReEeat testing 7 (14.00%) 43 (86.00%) 50 (100.00%) 
P, test of proportion; P=O.0002; PTSD = posttraumatic stress disorder; VMA = vanillylmandelic acid 
Table 2. Concurrent determination of elevated VMAJ decreased cortisol and cerebral 
vasospasm: PTSD patient initial testing vs. control group 
Group 
Elevated VMA + 
Other Total 
decreased cortisol + vasospasm 
PTSD patients 
25 (50.00%) 25 (50.00%) 50 (100.00%) 
Initial testing 
Control group 0(0.00%) 50 (100.00%) 50 (100.00%) 
P, test of proportion; P=O.OOOO; PTSD = posttraumatic stress disorder; VMA = vanillylmandelic acid 
Table 3. Concurrent determination of normal VMAJ normal cortisol and cerebral 




normal cortisol + vasospasm 
PTSD patients 
2 (4.00%) 48 (96.00%) 50 (100.00%) 
Initial testing 
PTSD patients 
1 (2.00%) 49 (98.00%) 50 (100.00%) 
Repeat testing 
P, test of proportion; P=O.5591; PTSD = posttraumatic stress disorder; VMA = vanillylmandelic acid 
Table 4. Concurrent determination of normal VMAJ normal cortisol and cerebral 




normal cortisol + vasospasm 
PTSD patients 
2 (4.00%) 48 (96.00%) 50 (100.00%) 
Initial testing 
Control group 2 (4.00%) 48 (96.00%) 50 (100.00%) 
P, test of proportion; P=1.0000; PTSD = posttraumatic stress disorder; VMA = vanillylmandelic acid 
patients and control subjects was statistically signifi-
cant (P=O.OOOO) (Table 2). In the group of chronic 
PTSD patients, normal levels of24-h VMA and 24-h 
cortisol with the presence of cerebral vasospasm were 
recorded in two (4.00%) patients on initial testing and 
in one (2.00%) patient on repeat testing; the difference 
did not reach statistical significance (P=0.5591) (Ta-
ble 3). As normal levels of the same parameters were 
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recorded in two (4.00%) control subjects, there was 
no statistically significant difference from the group of 
chronic PTSD patients (P=1.0000) (Table 4). 
Discussion 
Patients with untreated chronic PTSD showed a 
significantly higher rate of elevated VMA and de-
creased cortisol levels, along with a high prevalence 
of vasospasm in the circle of Willis vasculature. None 
of the control subjects had such a pattern of study 
parameters. Although 3-week psychopharmaceuti-
cal therapy resulted in significant improvement of the 
findings in PTSD patients, a significantly higher rate 
of abnormal findings in comparison to the control 
group persisted on repeat testing. A high correlation 
between elevated catecholamine level, decreased cor-
tisollevel and cerebral vasospasm was found on both 
initial and repeat testing. 
Chronic PTSD patients have impaired biologi-
cal response to stress due to failure in the mechanism 
of negative feedback. In the initial stage of disease, 
PTSD patients have elevated baseline cortisol level, 
followed by complete collapse of the hypothalamic-
pituitary-adrenal axis in chronic stage of the disease, 
resulting in decreased baseline cortisol level that now 
fails to play its physiologic role in stress situation22-24 . 
Studies have demonstrated an increased activity of 
the adrenergic system in stress. Daily stressful situa-
tions cause prompt increase of epinephrine and nor-
epinephrine secretion; catecholamine level normalizes 
soon upon stress cessation25,26. In spite of the stressful 
event having been experienced long before, PTSD pa-
tients develop pathologic response to stress, which re-
sults in elevated baseline catecholamine levels27-34 . The 
increased catecholamine level associated with stress 
response entails an increase in sympathetic tonus, 
which is in turn accompanied by clinical signs such 
as tachycardia, elevated blood pressure, mydriasis, hy-
perventilation, etc. These patients show a higher rate 
of elevated blood pressure and increased pulse rate as 
compared with their healthy age-mates35-31 
Catecholamine levels normalize soon upon stress 
cessation, resulting in disappearance of the accompa-
nying clinical manifestations38 The findings of elevat-
ed 24-h VMA level along with decreased cortisol lev-
el have already been reported in PTSD patients9•39.40 
Our results confirmed these reports and pointed to 
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the value of 24-h VMA and 24-h cortisol determi-
nation in untreated PTSD patients before and after 
therapy introduction. 
Our previous studies pointed to increased flow 
rate in basal cerebral arteries in patients with chronic 
PTSD, associated with frequency spectrum chang-
es suggestive of vasospasm10,11 . The central nervous 
system and the circle of Willis vasculature contain 
exclusively adrenergic alpha 1 receptors. Stimula-
tion of these receptors induces vasoconstriction and 
vasospasm41-44 . Results of the present study confirmed 
the presence of cerebral vasospasm in the majority of 
PTSD patients and pointed to the role ofTCD as an 
important diagnostic method for detection and moni-
toring of hemodynamic changes in cerebral vascula-
ture of chronic PTSD patients. 
To the best of our knowledge, there are no litera-
ture reports on the study of correlation between el-
evated VMA levels, decreased cortisol level and cere-
bral hemodynamics in patients with chronic PTSD, 
only a functional testing demonstrating relatively 
rapid change of cerebral perfusion in some physiolog-
ic states has been reported. For example, intracranial 
arterial MBFV increased by 38%-66% from baseline 
was recorded as early as 3 minutes of cerebral circu-
lation acetazolamide stimulation. The acetazolamide 
test has proved highly useful in patients with athero-
sclerotic stenosis of carotid arteries. A higher grade 
of stenosis correlated with lower vasoreactivity in the 
ipsilateral cerebral hemisphere45-47. Functional brain 
testing with various cognitive stimuli such as read-
ing, light, sound, visualization, imagined speech, etc., 
showed MBFV increase in the brain regions activated 
by the respective stimuli. Upon stimulus cessation, the 
MBFV returned to basal values48 -51 Elevated MBFV 
were also detected in smokers, which is attributed to 
nicotine receptor stimulation, increased catecholamine 
secretion and indirectly induced cerebral vasospasm52 . 
The highest degree of vasospasm was found in patients 
with subarachnoid hemorrhage19-21,53. 
Clinical relevance of prolonged cerebral vasospasm 
found in patients with chronic PTSD has not yet been 
fully clarified. As PTSD patients have a higher rate of 
various risk factors for atherosclerosis, such as ciga-
rette smoking, alcoholism, arterial hypertension, obe-
sity, hyperlipidemias, diabetes mellitus, etc., the like-
lihood of developing atherosclerosis, cerebrovascular 
and cardiovascular diseases is significantly greater 
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as compared with general population12-16 ,54-56. There-
fore, additional studies of the association between 
pathophysiologic changes and cerebral circulation 
in PTSD patients are warranted, along with proper 
monitoring of long-term somatic PTSD sequels. 
TeD analysis of cerebral circulation with concurrent 
determination of 24-h VMA and cortisol levels can 
help in the diagnosis of chronic PTSD, follow-up of 
the course of disease and assessment of psychiatric 
treatment outcome. 
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Saietak 
UCINAK STRESNIH HORMONA NA MOZDANU HEMODINAMIKU KOD BOLESNIKA S KRONICNIM 
POSTTRAUMATSKIM STRESNIM POREMECAJEM 
M. Dikanovii, D. Kadojii, V. Demarin, Z. Trkanjec, L Mihaljevii, M. Bitunjac, M. Kadojii, L Matic, L. Sapina, V. Vuletiii 
Lj. Cengii 
Cilj ovoga rada bio je utvrditi mogucu povezanost izmedu razine kateholamina, kortizoia i promjena cerebraine hemo-
dinamike u boiesnika s kronicnim posttraumatskim stresnim poremeeajem (PTSP). Ispitivanjem je obuhvaceno 50 bole-
snika s kronicnim PTSP koji su prvi put hospitalizirani i psihijatrijski lijeceni te 50 zdravih ispitanika kontroine skupine. 
Svi ispitanici bili su u dobi izmedu 30 i 50 godina. U boiesnika s PTSP su prvoga dana boravka analizirane vrijednosti 
vanilmandelicne kiseline (VMA), metabolita adrenalina i noradrenalina te kortizoia u 24-satnoj mokraCi i ucinjena je 
transkranijska dopIer sonografija (TCD). Isti dijagnostiCki postupci ponovijeni su nakon 21-dnevnog medikamentnog 
psihijatrijskog lijecenja. Prva analiza pokazaia je istodobno povisenu razinu 24-satne VMA, sniieni kortizol i povisene 
srednje brzine strujanja krvi (SBSK) krvnih ilia Willisova kruga u 25 (50,00010) bolesnika. Druga analiza koja je uCinje-
na nakon 21-dnevnog psihijatrijskog lijecenja pokazaia je istodobno povisenu razinu 24-satne VMA, sniieni kortizol i 
povisene SBSK krvnih iiIa Willisova kruga u 7 (14,00%) bolesnika (odnos prve i druge analize P=0,0002), dok u kon-
troinoj skupini nije pronaden niti jedan takav ispitanik s navedenim parametrima (odnos prve analize i kontroine skupine 
P=O,OOOO). Istraiivanje je pokazalo znaeajnu povezanost povisene razine kateholamina, sniienog kortizoia i povisenih 
SBSK u krvnim iilama Willisova kruga koje su uzrokovane cerebrainim vazospazmom. Medikamentno psihijatrijsko 
lijecenje PTSP u trajanju od tri tjedna dovelo je do znaeajnog smanjenja udjela boiesnika s istodobno promijenjenom cere-
brainom hemodinamikom, povisenom razinom metabolita kateholamina i smanjenom razinom kortizola. 
KIjucne rijeci: Stresni poremeia): posttraumatski; Stresni poremeia): posttraumatski - jiziopatologiJa; Cerebrovaskularna cirku-
laciJa - jiziologiJa; Moidano krvarenje - etiologija; Mowano krvarenje - jiziopatologija; Moidano krvarenje - ultrazvuk; Hemo-
dinamski procesi - jiziologija 
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